Related references
Note: Only part of the references are listed.Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways
Lueder Hinrich Meyer et al.
CANCER CELL (2011)
Using a Stem Cell-Based Signature to Guide Therapeutic Selection in Cancer
Igor Shats et al.
CANCER RESEARCH (2011)
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Christina Scheel et al.
CELL (2011)
The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse
Anna Merlos-Suarez et al.
CELL STEM CELL (2011)
Genetic variegation of clonal architecture and propagating cells in leukaemia
Kristina Anderson et al.
NATURE (2011)
Stem cell gene expression programs influence clinical outcome in human leukemia
Kolja Eppert et al.
NATURE MEDICINE (2011)
Cancer Stem Cells and Self-renewal
Catherine Adell O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
Andrew J. Gentles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Molecular Signatures of Quiescent, Mobilized and Leukemia-Initiating Hematopoietic Stem Cells
E. Camilla Forsberg et al.
PLOS ONE (2010)
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Angelo Cicalese et al.
CELL (2009)
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Mark Shackleton et al.
CELL (2009)
Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells
Tim C. P. Somervaille et al.
CELL STEM CELL (2009)
The Increasing Complexity of the Cancer Stem Cell Paradigm
Jeffrey M. Rosen et al.
SCIENCE (2009)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
High EVI1 expression predicts poor survival in acute myeloid leukemia:: a study of 319 de novo AML patients
SBV van Doorn-Khosrovani et al.
BLOOD (2003)